JP2007518732A5 - - Google Patents

Download PDF

Info

Publication number
JP2007518732A5
JP2007518732A5 JP2006548383A JP2006548383A JP2007518732A5 JP 2007518732 A5 JP2007518732 A5 JP 2007518732A5 JP 2006548383 A JP2006548383 A JP 2006548383A JP 2006548383 A JP2006548383 A JP 2006548383A JP 2007518732 A5 JP2007518732 A5 JP 2007518732A5
Authority
JP
Japan
Prior art keywords
polymer
organisms
complex
pathogenic
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006548383A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007518732A (ja
Filing date
Publication date
Priority claimed from GBGB0400264.8A external-priority patent/GB0400264D0/en
Application filed filed Critical
Publication of JP2007518732A publication Critical patent/JP2007518732A/ja
Publication of JP2007518732A5 publication Critical patent/JP2007518732A5/ja
Pending legal-status Critical Current

Links

JP2006548383A 2004-01-07 2005-01-07 アジュバント活性を有する複合体 Pending JP2007518732A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0400264.8A GB0400264D0 (en) 2004-01-07 2004-01-07 Complexes
PCT/GB2005/000039 WO2005065712A2 (en) 2004-01-07 2005-01-07 Complexes having adjuvant activity

Publications (2)

Publication Number Publication Date
JP2007518732A JP2007518732A (ja) 2007-07-12
JP2007518732A5 true JP2007518732A5 (enExample) 2008-02-07

Family

ID=31503533

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006548383A Pending JP2007518732A (ja) 2004-01-07 2005-01-07 アジュバント活性を有する複合体

Country Status (10)

Country Link
US (1) US20090176866A1 (enExample)
EP (1) EP1701741B1 (enExample)
JP (1) JP2007518732A (enExample)
CN (1) CN1909928B (enExample)
AT (1) ATE396742T1 (enExample)
AU (1) AU2005203908B2 (enExample)
DE (1) DE602005007177D1 (enExample)
ES (1) ES2308432T3 (enExample)
GB (1) GB0400264D0 (enExample)
WO (1) WO2005065712A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0316294D0 (en) * 2003-07-11 2003-08-13 Polytherics Ltd Conjugated biological molecules and their preparation
GB0722080D0 (en) * 2007-11-09 2007-12-19 Polytherics Ltd Novel complexes and a process for their preparation
CN105153300A (zh) 2008-06-30 2015-12-16 艾斯巴技术-诺华有限责任公司 官能化的多肽
BRPI0915460A2 (pt) 2008-07-10 2015-11-10 Esbatech Alcon Biomed Res Unit métodos e composições para a liberação intensificada de macromoléculas
GB201210358D0 (en) * 2012-06-12 2012-07-25 Polytherics Ltd Complexes
PT3471760T (pt) 2016-06-17 2025-01-20 Sanofi Pasteur Sa Formulações imunogénicas inovadoras compreendendo adjuvantes de polímero de ácido poliacrílico linear ou ramificado

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5160737A (en) * 1988-05-03 1992-11-03 Perio Products Ltd. Liquid polymer composition, and method of use
US5130126A (en) * 1990-07-09 1992-07-14 Nippon Oil & Fats Co., Ltd. Polymer-drug conjugate and a method of producing it
CA2072072A1 (en) * 1990-10-24 1992-04-25 Masayuki Kuzuya Organic polymer compound and production thereof
DE4337945A1 (de) * 1993-11-06 1995-05-11 Labtec Gmbh Pflaster zur Behandlung von Nagelmykosen
GB2290707A (en) * 1994-06-28 1996-01-10 Georgi Stankov Pharmaceutical uses of Amphotericin B
CA2299117A1 (en) * 1999-02-24 2000-08-24 Stiefel Research Institute, Inc. Antimycotic compositions
JP4883515B2 (ja) * 1999-09-08 2012-02-22 ポリセリックス リミテッド 均一分子量ポリマー
MY129765A (en) * 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
EP1383376A4 (en) * 2001-03-19 2006-03-08 Praecis Pharm Inc PHARMACEUTICAL FORMULATIONS WITH PROLONGED RELEASE
BR0105500A (pt) * 2001-11-05 2004-06-22 Univ Minas Gerais Processo de obtenção de dispersões coloidais de anfotericina b; composições à base de anfotericina b de uso enteral, parenteral e tópico; uso destas composições no tratamento de micoses sistêmicas e infecções parasitárias

Similar Documents

Publication Publication Date Title
US8324333B2 (en) Anionic charge-dynamic polymers for release of cationic agents
JP6175451B2 (ja) ポリマー担体カーゴ複合体と少なくとも１つのタンパク質又はペプチド抗原とを含む医薬組成物
Gambaryan et al. Polymeric inhibitor of influenza virus attachment protects mice from experimental influenza infection
JP2019509339A5 (enExample)
JP2012017342A5 (enExample)
CA2637765A1 (en) Benzamide and heteroarene derivatives
JPWO2009041570A1 (ja) ステロイド類の高分子結合体
Smith et al. Macromolecular (pro) drugs in antiviral research
Desai et al. Nanoadjuvants: promising bioinspired and biomimetic approaches in vaccine innovation
Hsu et al. Polyphosphazenes for the delivery of biopharmaceuticals
Yu et al. Quaternized chitosan nanoparticles in vaccine applications
WO2021216467A1 (en) A nano-enabled vaccination approach for coronavirus disease (covid-19) and other viral diseases
JP2016531895A5 (enExample)
Orosco et al. Navigating the landscape of adjuvants for subunit vaccines: recent advances and future perspectives
TWI861015B (zh) 包含抗原肽-佐劑核苷酸結合物之免疫誘導劑及包含其之醫藥組成物
CA2840974A1 (en) Vaccine composition for mucosal administration
JP2007518732A5 (enExample)
Aderibigbe Polymeric therapeutic delivery systems for the treatment of infectious diseases
CN101360514A (zh) 基于双酰氧基丙基半胱氨酸缀合物及其衍生物的新佐剂及其在药物组合物中的用途
Akilesh M et al. Novel applications of nanotechnology in controlling HIV and HSV infections
US20150024001A1 (en) Molecular mimic mucosal aids vaccine
EP1701741B1 (en) Complexes having adjuvant activity
JPWO2009133863A1 (ja) Ｅｐ１アゴニストを含有してなる免疫増強剤
JP2019172707A (ja) スクアレンを含む両親媒性ポリアミノ酸高分子に基づくワクチンの免疫補助剤組成物
JP2012526847A5 (enExample)